Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Ayurcann signs supply agreement to have products sold on CannMart and Patients Choice platforms.

Ayurcann signs supply agreement to have products sold on CannMart and Patients Choice platforms.

Ayurcann Holdings (CSE: AYUR) CEO Igal Sudman joined Steve Darling from Proactive to shares news the company has signed a two supply deals with medical cannabis product suppliers, CannMart Inc and Patient Choice to sell branded products directly to medical patient consumers.

Sudman shared with Proactive consumers will soon be able to choose Ayurcann products like XPLOR Pure CBD 1000 Tincture, Fuego Vena Grad 1g Vape Cartridge, Fuego Cheri Amour 1g Vape Cartridge, Fuego La Padres 1g Vape Cartridge, and finally the Xplor Balanced 250 Tincture.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK